CTXR
Citius Pharmaceuticals (CTXR)
$71
About Citius Pharmaceuticals (CTXR)
Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone, Leonard Mazur, Myron Holubiak on January 23, 2007 and is headquartered in Cranford, NJ.
Details
Daily high
$0.75
Daily low
$0.68
Price at open
--
52 Week High
$2.48
52 Week Low
$0.63
Market cap
15.9M
Dividend yield
0.00%
Volume
35
Avg. volume
785,090
P/E ratio
-.25
Citius Pharmaceuticals News
Details
Daily high
$0.75
Daily low
$0.68
Price at open
--
52 Week High
$2.48
52 Week Low
$0.63
Market cap
15.9M
Dividend yield
0.00%
Volume
35
Avg. volume
785,090
P/E ratio
-.25